Advertisement

Pharmaceutical Research

, Volume 11, Issue 12, pp 1825–1828 | Cite as

The Use of Multiple Doses and Pharmacodynamic System Analysis to Distinguish Between Dispositional Delays and Time-Variant Pharmacodynamics

  • Marc R. Gastonguay
  • Sorell L. Schwartz
Article

Abstract

Pharmacokinetic-pharmacodynamic modeling algorithms, in general, rely on hysteresis minimization techniques that assume time-invariant pharmacodynamics (constant biophase concentration-effect relationships). When time-variant pharmacodynamics are observed, a specific model for tolerance or sensitization is required. However, with single dosing, hysteresis that results from a time-variant biophase concentration-effect relationship cannot be distinguished from hysteresis caused by dispositional delays. This can lead to the inappropriate minimization of hysteresis. As an approach to this problem, simulated and real kinetic-dynamic data were analyzed with the pharmacodynamic system analysis program ATTRACT. The use of a multiple dosing regimen and this hysteresis minimization algorithm resulted in a simple diagnostic test to distinguish between dispositional effects of acute tolerance and sensitization.

pharmacodynamic system analysis hysteresis time-variant pharmacodynamics dispositional delay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    P. Veng-Pedersen, and N. Modi. Pharmacodynamic system analysis of the biophase level predictor and the transduction function. J. Pharm. Sci. 81:925–934, 1992.Google Scholar
  2. 2.
    N. H. G. Holford and L. B. Sheiner. Understanding of dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 6:429–453, 1981.Google Scholar
  3. 3.
    H. C. Porchet, N. L. Benowitz, and L. B. Sheiner. Pharmacodynamic model of tolerance: Application to nicotine. J. Pharmacol. Exp. Ther. 244:231–236, 1988.Google Scholar
  4. 4.
    P. Veng-Pedersen, and N. Modi. A system approach to pharmacodynamics. Input-effect control system analysis of central nervous system effect of alfentanil. J. Pharm. Sci. 82:266–272, 1993.Google Scholar
  5. 5.
    M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd edition, Marcel Dekker, Inc.: New York, 1982.Google Scholar
  6. 6.
    H. C. Porchet, N. L. Benowitz, L. B. Sheiner and J. R. Copeland. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J. Clin. Invest. 80:1466–1471, 1987Google Scholar
  7. 7.
    N. L. Benowitz. Pharmacokinetics and pharmacodynamics of nicotine, in Pharmacology of Nicotine, ICSU Symposium Series, 9, 1988.Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Marc R. Gastonguay
    • 1
  • Sorell L. Schwartz
    • 1
  1. 1.Toxicology and Applied Pharmacokinetics Program, Department of PharmacologyGeorgetown University School of MedicineWashington

Personalised recommendations